Foreign Direct Investment in Pharmaceuticals Sector – Clarification

The extant FDI policy for pharmaceutical sector has since been reviewed by the Reserve Bank of India and it has now been decided with immediate effect that the existing policy would continue with the condition that ‘non-compete’ clause would not be allowed except in special circumstances with the approval of the Foreign Investment Promotion Board (FIPB) of the Govt. of India.